Telomir Pharmaceuticals, Inc. (TELO)
0.88
+0.10
(+12.81%)
USD |
NASDAQ |
Nov 06, 10:27
Telomir Pharmaceuticals EPS Diluted (Quarterly) : -0.7863 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7863 |
| March 31, 2026 | -0.0288 |
| December 31, 2025 | -0.06 |
| September 30, 2025 | -0.034 |
| June 30, 2025 | -0.1689 |
| March 31, 2025 | -0.0732 |
| December 31, 2024 | -0.0975 |
| September 30, 2024 | -0.2023 |
| June 30, 2024 | -0.0489 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.2252 |
| December 31, 2023 | -0.315 |
| September 30, 2023 | -0.0578 |
| June 30, 2023 | -0.0524 |
| March 31, 2023 | -0.0163 |
| December 31, 2022 | -0.0164 |
| September 30, 2022 | -0.0079 |
| June 30, 2022 | -0.0024 |
| March 31, 2022 | -0.0021 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.722M |
| Total Expenses (Quarterly) | 1.722M |
| Enterprise Value | 48.62M |
| Earnings Yield | -103.3% |
| Normalized Earnings Yield | -103.31 |